Suppr超能文献

台湾华裔急性淋巴细胞白血病儿童中与巯嘌呤不耐受相关的NUDT15基因多态性

NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia.

作者信息

Liang D-C, Yang C-P, Liu H-C, Jaing T-H, Chen S-H, Hung I-J, Yeh T-C, Lin T-H, Lai C-L, Lai C-Y, Shih L-Y

机构信息

Division of Pediatric Hematology-Oncology, Mackay Children's Hospital and Mackay Medical College, Taipei, Taiwan.

Division of Pediatric Hematology-Oncology, Chang Gung Children's Hospital, Taoyuan, Taiwan.

出版信息

Pharmacogenomics J. 2016 Nov;16(6):536-539. doi: 10.1038/tpj.2015.75. Epub 2015 Oct 27.

Abstract

A recent study identified a variant of the NUDT15 gene (rs116855232 C>T) associated with intolerance to thiopurine in Korean patients with Crohn's disease. This study prompted us to substantiate the finding in a Taiwanese population. Four hundred and four children with acute lymphoblastic leukemia (ALL), and 100 adults with chronic immune thrombocytopenic purpura or localized lymphoma having normal bone marrow were examined. Two candidate gene approaches, pyrosequencing for NUDT15 and TaqMan assay for thiopurine methyltransferase (TPMT) genotyping (rs1142345 A>G), were performed. We showed a risk allele frequency of NUDT15 of 11.6% in children with ALL and 15.5% in adults. By contrast, the risk allele frequency of TPMT was only 1.6% in children with ALL and 0.5% in adults. The high frequency of risk variant for NUDT15, but not the very low frequency of risk variant for TPMT, was closely associated with the intolerance to mercaptopurine in children with ALL in Taiwan, contrast to that of European descent. In regard to NUDT15 polymorphism, the maximal tolerable daily doses of mercaptopurine in homozygotes, heterozygotes and wild-type groups were 9.4 mg m, 30.7 mg m and 44.1 mg m, respectively. The outcomes did not differ significantly among the different genotypes.

摘要

最近一项研究发现,韩国克罗恩病患者中,NUDT15基因的一个变体(rs116855232 C>T)与硫嘌呤不耐受有关。这项研究促使我们在台湾人群中证实这一发现。我们检测了404例急性淋巴细胞白血病(ALL)患儿以及100例患有慢性免疫性血小板减少性紫癜或局限性淋巴瘤且骨髓正常的成年人。采用了两种候选基因方法,即对NUDT15进行焦磷酸测序以及对硫嘌呤甲基转移酶(TPMT)基因分型(rs1142345 A>G)进行TaqMan检测。我们发现,ALL患儿中NUDT15风险等位基因频率为11.6%,成人中为15.5%。相比之下,ALL患儿中TPMT风险等位基因频率仅为1.6%,成人中为0.5%。与欧洲血统人群不同,台湾ALL患儿中NUDT15风险变体的高频率,而非TPMT风险变体的极低频率,与对巯嘌呤的不耐受密切相关。关于NUDT15多态性,纯合子、杂合子和野生型组中巯嘌呤的最大可耐受日剂量分别为9.4 mg/m、30.7 mg/m和44.1 mg/m。不同基因型之间的结果没有显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验